{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:22:36Z","timestamp":1760980956601},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,2,1]],"date-time":"1995-02-01T00:00:00Z","timestamp":791596800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1995,2]]},"DOI":"10.1007\/bf02246102","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T10:33:53Z","timestamp":1132050833000},"page":"275-286","source":"Crossref","is-referenced-by-count":46,"title":["Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset"],"prefix":"10.1007","volume":"117","author":[{"given":"Kanna K.","family":"Gnanalingham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilek D.","family":"Erol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Jackie","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. David","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02246102_CR1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(85)90345-0","volume":"113","author":"J Arnt","year":"1985","unstructured":"Arnt J (1985a) Behavioural stimulation is induced by separate dopamine D1 and D2 receptors in reserpine-pretreated but not in normal rats. Eur J Pharmacol 113:79\u201388","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0024-3205(85)90541-7","volume":"37","author":"J Arnt","year":"1985","unstructured":"Arnt J (1985b) Hyperactivity induced by stimulation of separate dopamine D1 and D2 receptors in rats with bilateral 6-OHDA lesions. Life Sci 37:717\u2013723","journal-title":"Life Sci"},{"key":"BF02246102_CR3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0014-2999(84)90267-X","volume":"102","author":"J Arnt","year":"1984","unstructured":"Arnt J, Hyttel J (1984) Differential inhibition by dopamine D1 and D2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions. Eur J Pharmacol 102:349\u2013354","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0014-2999(92)90690-6","volume":"213","author":"J Arnt","year":"1992","unstructured":"Arnt J, Hyttel J, Sanchez C (1992) Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur J Pharmacol 213:259\u2013267","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0304-3940(86)90496-9","volume":"69","author":"G Battaglia","year":"1986","unstructured":"Battaglia G, Norman AB, Hess EJ, Creese I (1986) Functional recovery of D1 dopamine receptor mediated stimulation of rat striatal adenylate cyclase activity following irreversible modification byN-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors. Neurosci Lett 69:290\u2013295","journal-title":"Neurosci Lett"},{"key":"BF02246102_CR6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-3940(89)90358-3","volume":"104","author":"PJ Bedard","year":"1989","unstructured":"Bedard PJ, Boucher R (1989) Effect of D1 receptor stimulation in normal and MPTP monkeys. Neurosci Lett 104:223\u2013228","journal-title":"Neurosci Lett"},{"key":"BF02246102_CR7","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/0024-3205(84)90540-X","volume":"35","author":"W Billard","year":"1984","unstructured":"Billard W, Ruperto V, Crosby G, Iorio LC, Barnett A (1984) Characterisation of the binding of [3H]-SCH 23390, a selective D\u22121 receptor antagonist ligand, in rat striatum. Life Sci 35:1885\u20131893","journal-title":"Life Sci"},{"key":"BF02246102_CR8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.40.6.927","volume":"40","author":"S Boyce","year":"1990","unstructured":"Boyce S, Rupniak NMJ, Steventon MJ, Iversen SD (1990) Differential effects of D1 and D2 agonists in MPTP-treated primates: Functional implications for Parkinson's disease. Neurology 40:927\u2013933","journal-title":"Neurology"},{"key":"BF02246102_CR9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(86)90588-1","volume":"131","author":"AR Braun","year":"1986","unstructured":"Braun AR, Chase TN (1986) Obligatory D1\/D2 receptor interaction in the generation of dopamine agonist related behaviours. Eur J Pharmacol 131:301\u2013306","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1476-5381.1985.tb08863.x","volume":"85","author":"SP Close","year":"1985","unstructured":"Close SP, Marriott AS, Pay S (1985) Failure of SKF 38393-A to relieve parkinsonian symptoms induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset. Br J Pharmacol 85:320\u2013322","journal-title":"Br J Pharmacol"},{"key":"BF02246102_CR11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02244093","volume":"102","author":"SP Close","year":"1990","unstructured":"Close SP, Elliott PJ, Hayes AG, Marriott AS (1990) Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's disease. Psychopharmacology 102:295\u2013300","journal-title":"Psychopharmacology"},{"key":"BF02246102_CR12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF02244250","volume":"103","author":"P Collins","year":"1991","unstructured":"Collins P, Broekkamp CLE, Jenner P, Marsden CD (1991) Drugs acting at D\u22121 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation. Psychopharmacology 103:503\u2013512","journal-title":"Psychopharmacology"},{"key":"BF02246102_CR13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/026988119200600111","volume":"6","author":"SA Daly","year":"1992","unstructured":"Daly SA, Waddington JL (1992) D1 dopamine receptors and the topography of unconditioned motor behaviour: studies with the selective, \u2018full efficacy\u2019 benzazepine D1 agonist SKF 83189. J Psychopharmacol 6:50\u201360","journal-title":"J Psychopharmacol"},{"key":"BF02246102_CR14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(91)90459-4","volume":"199","author":"MP DeNinno","year":"1991","unstructured":"DeNinno MP, Schoenleber R, MacKenzie R, Britton DR, Asin KE, Briggs C, Trugman JM, Ackerman M, Artman L, Bednarz L, Bhatt R, Curzon P, Gomez E, Kang CH, Stitts J, Kebabian JW (1991) A68930: a potent agonist selective for the dopamine D1 receptor. Eur J Pharmacol 199:209\u2013219","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR15","first-page":"1387","volume":"265","author":"EF Domino","year":"1993","unstructured":"Domino EF, Sheng J (1993) Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys. J Pharmacol Exp Ther 265:1387\u20131391","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246102_CR16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0014-2999(93)90718-W","volume":"234","author":"RP Downes","year":"1993","unstructured":"Downes RP, Waddington JL (1993) Grooming and vacuous chewing induced by SKF 83959 and agonist of dopamine \u2018D1 like\u2019 receptors that inhibits dopamine sensitive adenylyl cyclase. Eur J Pharmacol 234:135\u2013136","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-2999(90)94802-5","volume":"178","author":"C Gagnon","year":"1990","unstructured":"Gagnon C, Bedard PJ, Di Paolo T (1990) Effect of chronic treatment of MPTP monkeys with dopamine D1 and\/or D2 receptor agonists. Eur J Pharmacol 178:115\u2013120","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/syn.890140212","volume":"14","author":"KK Gnanalingham","year":"1993","unstructured":"Gnanalingham KK, Smith LA, Hunter AJ, Jenner P, Marsden CD (1993) Alterations in striatal and extrastriatal D1 and D2 dopamine receptors in the MPTP-treated common marmoset \u2014 an autoradiographic study. Synapse 14:184\u2013194","journal-title":"Synapse"},{"key":"BF02246102_CR19","doi-asserted-by":"crossref","unstructured":"Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD (1994) Selective protection of striatal\/extrastriatal D1\/D2 receptors from inactivation byN-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: an autoradiographic study. Neuropharmacology (in press)","DOI":"10.1016\/0028-3908(94)90170-8"},{"key":"BF02246102_CR20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1476-5381.1982.tb09285.x","volume":"77","author":"AJ Gower","year":"1982","unstructured":"Gower AJ, Marriott AS (1982) Pharmacological evidence for the subclassification of central dopamine receptors in the rat. Br J Pharmacol 77:185\u2013194","journal-title":"Br J Pharmacol"},{"key":"BF02246102_CR21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0306-4522(92)90155-U","volume":"46","author":"D Herve","year":"1992","unstructured":"Herve D, Trovero F, Blanc G, Glowinski J, Tassin JP (1992) Autoradiographic identification of D1 dopamine receptors labelled with [3H]-dopamine: distribution, regulation and relationship to coupling. Neuroscience 46:687\u2013700","journal-title":"Neuroscience"},{"key":"BF02246102_CR22","first-page":"50","volume":"31","author":"EJ Hess","year":"1987","unstructured":"Hess EJ, Battaglia G, Norman AB, Creese I (1987) Differential modification of striatal D1 dopamine receptors and effector moieties byN-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro. J Pharmacol Exp Ther 31:50\u201357","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246102_CR23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-2999(84)90324-8","volume":"100","author":"Y Itoh","year":"1984","unstructured":"Itoh Y, Beaulieu M, Kebabian JW (1984) The chemical basis for the blockade of the D1 dopamine receptor by SCH 23390. Eur J Pharmacol 100:119\u2013122","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0922-4106(93)90007-V","volume":"246","author":"S Izenwasser","year":"1993","unstructured":"Izenwasser S, Katz JL (1993) Differential efficacies of dopamine D1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat. Eur J Pharmacol [Mol Pharmacol] 246:39\u201344","journal-title":"Eur J Pharmacol [Mol Pharmacol]"},{"key":"BF02246102_CR25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","volume":"277","author":"JW Kebabian","year":"1979","unstructured":"Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93\u201396","journal-title":"Nature"},{"key":"BF02246102_CR26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-2999(92)90556-J","volume":"229","author":"JW Kebabian","year":"1992","unstructured":"Kebabian JW, Britton DR, DeNinno MP, Perner R, Smith L, Jenner P, Schoenleber R, Williams M (1992) A77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets. Eur J Pharmacol 229:203\u2013209","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0166-4328(90)90178-H","volume":"38","author":"GJ LaHoste","year":"1990","unstructured":"LaHoste GJ, Marshall JF (1990) Nigral D1 and striatal D2 receptors mediate the behavioural effects of dopamine agonists. Behav Brain Res 38:233\u2013242","journal-title":"Behav Brain Res"},{"key":"BF02246102_CR28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0006-2952(78)90233-2","volume":"27","author":"JE Leysen","year":"1978","unstructured":"Leysen JE, Commeren W, Laduron PM (1978) Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. Biochem Pharmacol 27:307\u2013316","journal-title":"Biochem Pharmacol"},{"key":"BF02246102_CR29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF02244422","volume":"105","author":"PA Loschmann","year":"1991","unstructured":"Loschmann PA, Smith LA, Lange KW, Jaehnig P, Jenner P, Marsden CD (1991) Motor activity following the administration of selective D1 and D2 dopaminergic drugs to normal common marmosets. Psychopharmacology 105:303\u2013309","journal-title":"Psychopharmacology"},{"key":"BF02246102_CR30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF02245479","volume":"109","author":"PA Loschmann","year":"1992","unstructured":"Loschmann PA, Smith LA, Lange KW, Jaehnig P, Jenner P, Marsden CD (1992) Motor activity following the administration of selective D1 and D2 dopaminergic drugs to MPTP-treated common marmosets. Psychopharmacology 109:49\u201356","journal-title":"Psychopharmacology"},{"key":"BF02246102_CR31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-2999(89)90690-0","volume":"166","author":"TW Lovenberg","year":"1989","unstructured":"Lovenberg TW, Brewster WK, Mottola DM, Lee RC, Riggs RM, Nichols DE, Lewis MH, Mailman RB (1989) Dihydrexidine, a novel selective high potency full dopamine D1 receptor agonist. Eur J Pharmacol 166:111\u2013113","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR32","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1471-4159.1988.tb01830.x","volume":"51","author":"BK Madras","year":"1988","unstructured":"Madras BK, Fahey MA, Canfield DR, Spealman RD (1988) D1 and D2 dopamine receptors in caudate-putamen of non-human primates (Macaca fascicularis). J Neurochem 51:934\u2013943","journal-title":"J Neurochem"},{"key":"BF02246102_CR33","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1073\/pnas.87.6.2196","volume":"87","author":"LC Mahan","year":"1990","unstructured":"Mahan LC, Burch RM, Monsma FJ, Sibley DR (1990) Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilisation inXenopus oocytes. Proc Natl Acad Sci 87:2196\u20132200","journal-title":"Proc Natl Acad Sci"},{"key":"BF02246102_CR34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4684-5191-7_4","volume":"204","author":"RB Mailman","year":"1986","unstructured":"Mailman RB, Schulz DW, Kilts CD, Lewis MH, Rollema H, Wyrick S (1986) The multiplicity of the D1 dopamine receptor. Neurobiology of central D1 dopamine receptors. In: Breese GR, Creese I (eds) Advances in Experimental Medicine and Biology 204:53\u201372","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"BF02246102_CR35","first-page":"59","volume-title":"Proceedings of XIth international catecholamine symposium Part B: Central aspects","author":"R Markstein","year":"1988","unstructured":"Markstein R, Seiler NP, Vigouret JM, Urwyler S, Enz A, Dixon K (1988) Pharmacological properties of CY 208-243, and normal D1 agonists. In: Sandler M (ed.) Proceedings of XIth international catecholamine symposium Part B: Central aspects, Alan R Liss, New York, pp. 59\u201364"},{"key":"BF02246102_CR36","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.71.10.3883","volume":"71","author":"RK Mishra","year":"1974","unstructured":"Mishra RK, Gardener EL, Katzman R, Makman MH (1974) Enhancement of dopamine stimulated adenylate cyclase activity in rat caudate after lesions in the substantia nigra: evidence for denervation supersensitivity. Proc Natl Acad Sci USA 71:3883\u20133887","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02246102_CR37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF00427697","volume":"82","author":"AG Molloy","year":"1984","unstructured":"Molloy AG, Waddington JL (1984) Dopaminergic behaviour stereospecifically promoted by the D1 agonist R-SK&F 38393 and selectively blocked by the D1 antagonist SCH 23390. Psychopharmacology 82:409\u2013410","journal-title":"Psychopharmacology"},{"key":"BF02246102_CR38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF00177909","volume":"92","author":"AG Molloy","year":"1987","unstructured":"Molloy AG, Waddington JL (1987) Assessment of grooming and other behavioural responses to the D1 dopamine receptor agonist SKF 38393 and itsR- andS-enantiomers in the intact adult rat. Psychopharmacology 92:164\u2013168","journal-title":"Psychopharmacology"},{"key":"BF02246102_CR39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-2999(89)90093-9","volume":"160","author":"AM Murray","year":"1989","unstructured":"Murray AM, Waddington JL (1989) The induction of grooming and vacuous chewing by a series of selective D1 dopamine agonists: two directions of D1:D2 interaction. Eur J Pharmacol 160:377\u2013384","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR40","first-page":"850","volume":"257","author":"JL Neisewander","year":"1991","unstructured":"Neisewander JL, Lucki I, McGonigle P (1991) Behavioural and Neurochemical effects of chronic administration of reserpine and SKF 38393 in rats. J Pharmacol Exp Ther 257:850\u2013860","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246102_CR41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0304-3940(85)90037-0","volume":"57","author":"M Nomoto","year":"1985","unstructured":"Nomoto M, Jenner P, Marsden CD (1985) The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393 reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset. Neurosci Letts 57:37\u201341","journal-title":"Neurosci Letts"},{"key":"BF02246102_CR42","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1471-4159.1987.tb05623.x","volume":"48","author":"KM O'Boyle","year":"1987","unstructured":"O'Boyle KM, Waddington JL (1987) [3H]-SCH 23390 binding to human putamen D1 dopamine receptors: stereochemical and structure-affinity relationships among 1-phenyl-1H-3-benzazepine derivatives as a guide to D1 receptor topography. J Neurochem 48:1039\u20131042","journal-title":"J Neurochem"},{"key":"BF02246102_CR43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0028-3908(89)90036-1","volume":"28","author":"KM O'Boyle","year":"1989","unstructured":"O'Boyle KM, Gaitanopoulos DE, Brenner M, Waddington JL (1989) Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor. Neuropharmacology 28:401\u2013405","journal-title":"Neuropharmacology"},{"key":"BF02246102_CR44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0014-2999(91)90304-9","volume":"202","author":"C Pifl","year":"1991","unstructured":"Pifl C, Reither H, Hornykiewicz O (1991) Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum. Eur J Pharmacol 202:273\u2013276","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR45","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1111\/j.1471-4159.1992.tb10939.x","volume":"58","author":"C Pifl","year":"1992","unstructured":"Pifl C, Nanoff C, Schingnitz G, Schultz W, Hornykiewicz O (1992) Sensitisation of dopamine stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease. J Neurochem 58:1997\u20132004","journal-title":"J Neurochem"},{"key":"BF02246102_CR46","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1523\/JNEUROSCI.09-09-03326.1989","volume":"9","author":"GS Robertson","year":"1989","unstructured":"Robertson GS, Robertson HA (1989) Evidence thatl-dopa-induced rotational behaviour is dependent on both striatal and nigral mechanisms. J Neurosci 9:3326\u20133331","journal-title":"J Neurosci"},{"key":"BF02246102_CR47","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0006-8993(89)91689-2","volume":"503","author":"HA Robertson","year":"1989","unstructured":"Robertson HA, Peterson MR, Murphy K, Robertson GS (1989) D1 Dopamine receptor agonists selectively activate striatalc-fos independent of rotational behaviour. Brain Res 503:346\u2013349","journal-title":"Brain Res"},{"key":"BF02246102_CR48","unstructured":"Rogers DC, Reavill CA, Hunter AJ (1992) Comparison of the effects of selective D1 agonists on dopamine-mediated behaviour. Br J Pharmacol [Suppl] 100:409p"},{"key":"BF02246102_CR49","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/0024-3205(83)90155-8","volume":"33","author":"H Rosengarten","year":"1983","unstructured":"Rosengarten H, Schweitzer JW, Friedhoff AJ (1983) Induction of oral dyskinesias in naive rats by D1 stimulation. Life Sci 33:2479\u20132482","journal-title":"Life Sci"},{"key":"BF02246102_CR50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0024-3205(86)90434-0","volume":"39","author":"H Rosengarten","year":"1986","unstructured":"Rosengarten H, Schweitzer JW, Friedhoff AJ (1986) Selective dopamine D2 receptor reduction enhances a D1 mediated oral dyskinesia in rats. Life Sci 39:29\u201335","journal-title":"Life Sci"},{"key":"BF02246102_CR51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF02244098","volume":"102","author":"NMJ Rupniak","year":"1990","unstructured":"Rupniak NMJ, Tye SJ, Iversen SD (1990) Drug-induced purposeless chewing: animal model of dyskinesia or nausea? Psychopharmacology 102:325\u2013328","journal-title":"Psychopharmacology"},{"key":"BF02246102_CR52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00002826-199208000-00005","volume":"15","author":"NMJ Rupniak","year":"1992","unstructured":"Rupniak NMJ, Boyce S, Steventon M, Iversen SD (1992) Weak antiparkinsonian activity of the D1 agonist C-APB (SKF 82958) and lack of synergism with a D2 agonist in primates. Clinical Neuropharmacol 15:307\u2013309","journal-title":"Clinical Neuropharmacol"},{"key":"BF02246102_CR53","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1111\/j.1476-5381.1991.tb12354.x","volume":"103","author":"DF Schoors","year":"1991","unstructured":"Schoors DF, Vauquelin GP, Vos HD, Smets G, Velkeniers B, Vanhaelst L, Dupont AG (1991) Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells. Br J Pharmacol 103:1928\u20131934","journal-title":"Br J Pharmacol"},{"key":"BF02246102_CR54","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0014-2999(78)90148-6","volume":"50","author":"PE Setler","year":"1978","unstructured":"Setler PE, Sarau HM, Zirkle CL, Saunders HL (1978) The central effects of a novel dopamine agonist. Eur J Pharmacol 50:419\u2013430","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-6147(92)90025-2","volume":"13","author":"DR Sibley","year":"1992","unstructured":"Sibley DR, Monsma FJ (1992) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13:61\u201369","journal-title":"Trends Pharmacol Sci"},{"key":"BF02246102_CR56","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/294366a0","volume":"294","author":"JC Stoof","year":"1981","unstructured":"Stoof JC, Kebabian JW (1981) Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294:366\u2013368","journal-title":"Nature"},{"key":"BF02246102_CR57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0014-2999(91)90508-N","volume":"199","author":"JR Taylor","year":"1991","unstructured":"Taylor JR, Lawrence MS, Redmond DE, Elsworth JD, Roth RH, Nichols DE, Mailman RB (1991) Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys. Eur J Pharmacol 199:389\u2013391","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR58","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0014-2999(88)90322-6","volume":"156","author":"JA Temlett","year":"1988","unstructured":"Temlett JA, Chong PN, Oertel WH, Jenner P, Marsden CD (1988) The D-1 dopamine receptor partial agonist, CY 208-243, exhibits antiparkinsonian activity in the MPTP-treated marmoset. Eur J Pharmacol 156:197\u2013206","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR59","first-page":"987","volume":"253","author":"AS Undie","year":"1990","unstructured":"Undie AS, Friedman E (1990) Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther 253:987\u2013992","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246102_CR60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-2999(93)90076-T","volume":"24","author":"VJ Watts","year":"1993","unstructured":"Watts VJ, Lawler CP, Gilmore JH, Southerland SB, Nichols DE, Mailman RB (1993) Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF 38393) agonists in primates vs. rodents. Eur J Pharmacol 24:165\u2013172","journal-title":"Eur J Pharmacol"},{"key":"BF02246102_CR61","first-page":"645","volume":"10","author":"J Weinstock","year":"1985","unstructured":"Weinstock J, Hieble JP, Wilson JW (1985) The chemistry and pharmacology of 3-benzazepine derivatives. Drugs Future 10:645\u2013696","journal-title":"Drugs Future"},{"key":"BF02246102_CR62","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1021\/jm00161a029","volume":"29","author":"J Weinstock","year":"1986","unstructured":"Weinstock J, Ladd DL, Wilson JW, Brush CK, Yim NCF, Gallagher G, McCarthy ME, Silvestri J, Sarau HM, Flaim KE, Ackerman DM, Setler PE, Tobia AJ, Hahn RA (1986) Synthesis and renal vasodilator activity of some dopamine agonist 1-aryl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diols: halogen and methyl analogues of fenoldopam. J Med Chem 29:2315\u20132325","journal-title":"J Med Chem"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02246102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02246102\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02246102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T14:30:13Z","timestamp":1558017013000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02246102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["BF02246102"],"URL":"https:\/\/doi.org\/10.1007\/bf02246102","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}